iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/28116156
Electronic Cigarettes for Curbing the Tobacco-Induced Burden of Noncommunicable Diseases: Evidence Revisited with Emphasis on Challenges in Sub-Saharan Africa - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:4894352.
doi: 10.1155/2016/4894352. Epub 2016 Dec 25.

Electronic Cigarettes for Curbing the Tobacco-Induced Burden of Noncommunicable Diseases: Evidence Revisited with Emphasis on Challenges in Sub-Saharan Africa

Affiliations
Review

Electronic Cigarettes for Curbing the Tobacco-Induced Burden of Noncommunicable Diseases: Evidence Revisited with Emphasis on Challenges in Sub-Saharan Africa

Jobert Richie N Nansseu et al. Pulm Med. 2016.

Abstract

Introduction. This review examines whether electronic cigarettes (e-cigs) implementation or vulgarization in sub-Saharan Africa (SSA) could be helpful in curtailing the toll of tobacco smoking in the region. Discussion. There are about 1.3 billion smokers worldwide, with nearly 80% of them living in developing countries where the burden of tobacco-related illnesses and deaths is the heaviest. Studies report that e-cigs may facilitate smoking cessation, reduction, or abstinence and may pose only a small fraction of the risks of traditional tobacco cigarettes; e-cigs may also considerably reduce second-hand smoking. Thereby, implementation of e-cig use could help to substantially reduce the burden driven by tobacco smoking in SSA, in a particular context of lack of regulations and control policies towards this threat. However, the evidence is not clear on whether e-cigs are risk-free, especially if used in the long term. Conclusions. On the whole, if e-cigs were to be introduced in SSA, they should be strictly recommended to current and/or ex-smokers as a method to quit smoking or prevent relapse and never-smokers should be strongly encouraged to avoid using these devices. Bans on sales of e-cigs to youngsters should be legislated, e-cig advertisements prohibited, and their usage continuously controlled and monitored.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests with regard to this article.

Similar articles

Cited by

References

    1. GBD 2013 Risk Factors Collaborators, Forouzanfar M. H., Alexander L., Anderson H. R., Bachman V. F., Biryukov S. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;386(10010):2287–2323. doi: 10.1016/S0140-6736(15)00128-2. - DOI - PMC - PubMed
    1. World Health Organization. Global Status Report on Non Communicable Diseases 2014. Geneva, Switzerland: World Health Organization; 2014. Attaining the nine global noncommunicable diseases targets; a shared responsibility.
    1. Ama Moor V. J., Nansseu J. R., Nouaga M. E., et al. Assessment of the 10-year risk of cardiovascular events among a group of sub-Saharan African post-menopausal women. Cardiology Journal. 2016;23(2):123–131. doi: 10.5603/cj.a2015.0056. - DOI - PubMed
    1. Berlin I. Smoking-induced metabolic disorders: a review. Diabetes and Metabolism. 2008;34(4, part 1):307–314. doi: 10.1016/j.diabet.2008.01.008. - DOI - PubMed
    1. Islami F., Torre L. A., Jemal A. Global trends of lung cancer mortality and smoking prevalence. Translational Lung Cancer Research. 2015;4(4):327–338. - PMC - PubMed

MeSH terms